Ryan Asay | Vice President of Corporate Affairs |
David Meek | Chief Executive Officer |
Chuck Baum | President, Founder & Head of Research & Development |
Laurie Stelzer | Chief Financial Officer |
Jamie Christensen | Chief Scientific Officer |
Ben Hickey | Chief Commercial Officer |
Michael Schmidt | Guggenheim |
Tyler Van Buren | Cowen |
Jonathan Miller | Evercore |
Ben Burnett | Stifel |
Andrew Berens | SVB Securities |
Evan Seigerman | BMO Capital Markets |
Yigal Nochomovitz | Citi |
Mike Ulz | Morgan Stanley |
Maury Raycroft | Jefferies |
Jay Olson | Oppenheimer |
Good afternoon, and welcome to the Mirati Therapeutics Second Quarter 2022 Earnings Call. My name is Danielle, and I will be the operator for today's call. All lines have been placed on mute to prevent any background noise. After the conclusion of the speakers prepared remarks. There will be a question-and-answer session.